Latest filing published 10 Jul 2026 for UNITED THERAPEUTICS Corp.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jan Malcolm: trading record in brief
All filings by Jan Malcolm on record concern UNITED THERAPEUTICS Corp. In total, 13 filings cover trades dated from 26 June 2025 to 10 July 2026.
Sales make up the whole of the open-market record (10 sales, €562k). Other entries cover 3 option exercises. So far in 2026, the count stands at no purchases and 7 sales.
The newest entry dates from 10 July 2026: an option exercise, in UNITED THERAPEUTICS Corp. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jan Malcolm
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 650 shares0Common StockSEC:0002028640-26-000007:0
- 325 shares@ US$550.59Common StockSEC:0002028640-26-000007:1
- 45 shares@ US$533.51100.0% of flowCommon StockSEC:0002028640-26-000006:0
- 50 shares@ US$509.205.4% of flowCommon StockSEC:0002028640-26-000005:0
- 50 shares@ US$474.68Common StockSEC:0002028640-26-000004:0
- 50 shares@ US$474.23Common StockSEC:0002028640-26-000003:0
- 50 shares@ US$460.98Common StockSEC:0002028640-26-000002:0
- 50 shares@ US$495.01Common StockSEC:0002028640-26-000001:0
- 50 shares@ US$512.127.2% of flowCommon StockSEC:0002028640-25-000006:0
- 50 shares@ US$482.987.3% of flowCommon StockSEC:0002028640-25-000005:0
- 700 shares@ US$400.2992.0% of flowCommon StockSEC:0002028640-25-000004:0
- 630 shares0Common StockSEC:0001562180-25-005511:0
12 of 12 declarations
